GWS
ALNY icon

Glassman Wealth Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Glassman Wealth Services’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-146
Closed -$27.9K – 273
2023
Q4 		$27.9K Buy
146
+10
+7% +$1.7K ﹤0.01% 609
2023
Q3 		$24.1K Sell
136
-5
-4% -$954 ﹤0.01% 612
2023
Q2 		$26.8K Buy
141
+7
+5% +$1.39K ﹤0.01% 554
2023
Q1 		$26.8K Sell
134
-4
-3% -$841 ﹤0.01% 562
2022
Q4 		$32.8K Buy
138
+4
+3% +$853 0.01% 529
2022
Q3 		$27K Buy
134
+2
+2% +$381 0.01% 532
2022
Q2 		$19K Sell
132
-45
-25% -$6.38K ﹤0.01% 630
2022
Q1 		$29K Buy
177
+27
+18% +$4.11K 0.01% 533
2021
Q4 		$25K Buy
150
+13
+9% +$2.42K ﹤0.01% 545
2021
Q3 		$26K Buy
137
+2
+1% +$375 0.01% 509
2021
Q2 		$23K Buy
135
+2
+2% +$293 ﹤0.01% 532
2021
Q1 		$19K Sell
133
-2
-1% -$301 ﹤0.01% 537
2020
Q4 		$18K Buy
135
+69
+105% +$9.21K ﹤0.01% 553
2020
Q3 		$10K Buy
66
+13
+25% +$1.85K ﹤0.01% 599
2020
Q2 		$8K Buy
53
+28
+112% +$3.77K ﹤0.01% 527
2020
Q1 		$3K Buy
25
+3
+14% +$346 ﹤0.01% 587
2019
Q4 		$3K Hold
22
– – ﹤0.01% 651
2019
Q3 		$2K Buy
22
+18
+450% +$1.42K ﹤0.01% 665
2019
Q2 		$0 Sell
4
-9
-69% -$691 ﹤0.01% 1049
2019
Q1 		$1K Buy
+13
New +$1.09K ﹤0.01% 753
2018
Q2 		– Sell
-3
Closed – – 788
2018
Q1 		$0 Hold
3
– – ﹤0.01% 725
2017
Q4 		$0 Buy
+3
New +$377 ﹤0.01% 658

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Glassman Wealth Services's ALNY Position: Q1 2024 in Review

Glassman Wealth Services sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2024, closing a stake of 146 shares — an estimated $27.9K sold.

Glassman Wealth Services first reported a position in ALNY in Q4 2017 and held it in 22 quarters. The position peaked at $32.8K in Q4 2022. 499 funds tracked by Wall St. Rank hold ALNY as of Q1 2024.

  • Glassman Wealth Services reported no remaining Alnylam Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 146 Alnylam Pharmaceuticals shares in Q1 2024, an estimated $27.9K.
  • Glassman Wealth Services first reported a position in Alnylam Pharmaceuticals in Q4 2017 and held it in 22 quarters.
  • Glassman Wealth Services's Alnylam Pharmaceuticals position peaked at $32.8K in Q4 2022.
  • 499 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.